Regeneron Pharmaceuticals’ gene therapy for otoferlin-related hearing loss, a genetic cause of deafness, has restored hearing ...

Circio, a biotech firm specializing in circular RNA-based gene therapy, has unveiled two posters showcasing in vivo ...

Key competitors include Boehringer Ingelheim’s cathepsin C inhibitor BI-1291583, Regeneron’s anti-IL-33 monoclonal antibody ...

The US government’s unveiling of the BIOSECURE bill has created a great deal of discussion and debate in the pharma industry.

The Asia-Pacific (APAC) region is leading the way in the asthma clinical trials space, conducting the most studies globally ...

Calliditas Therapeutics has announced encouraging data from its proof-of-concept phase 2 trial evaluating setanaxib, its lead ...

The Danish biotech is pioneering a novel approach to activating the complement component of the immune system, to treat ...

Pfizer's groundbreaking $3.5 million gene therapy for Hemophilia B just got FDA approval. Here’s what it means for patients ...

UK-based pharma manufacturer Ennogen has received a £30 million credit facility from Santander UK to support its ...

Adare Pharma Solutions, a tech driven CDMO specializing in oral dosage forms, has announced expansions of its high potency ...

Almost half of all strategic alliances focused on RNA therapies over the last five years in the Asia-Pacific (APAC) region ...

Broken String Biosciences, a genomics company driving cell and gene therapy developing, has entered a research collaboration with the Francis Crick Institute, a biomedical discovery institute ...